Inhibition of carboxylesterases by benzil (diphenylethane-1,2-dione) and heterocyclic analogues is dependent upon the aromaticity of the ring and the flexibility of the dione moiety

被引:62
作者
Hyatt, JL
Stacy, V
Wadkins, RM
Yoon, KJP
Wierdl, M
Edwards, CC
Zeller, M
Hunter, AD
Danks, MK
Crundwell, G
Potter, PM
机构
[1] St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA
[2] Cent Connecticut State Univ, Dept Chem, New Britain, CT 06050 USA
[3] Univ Mississippi, Dept Chem & Biochem, University, MS 38677 USA
[4] Youngstown State Univ, Dept Chem, Youngstown, OH 44555 USA
关键词
D O I
10.1021/jm0504196
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Benzil has been identified as a potent selective inhibitor of carboxylesterases (CEs). Essential components of the molecule required for inhibitory activity include the dione moiety and the benzene rings, and substitution within the rings affords increased selectivity toward CEs from different species. Replacement of the benzene rings with heterocyclic substituents increased the K-i values for the compounds toward three mammalian CEs when using o-nitrophenyl acetate as a substrate. Logarithmic plots of the K-i values versus the empirical resonance energy, the heat of union of formation energy, or the aromatic stabilization energy determined from molecular orbital calculations for the ring structures yielded linear relationships that allowed prediction of the efficacy of the diones toward CE inhibition. Using these data, we predicted that 2,2'-naphthil would be an excellent inhibitor of mammalian CEs. This was demonstrated to be correct with a K-i value of 1 nM being observed for a rabbit liver CE. In addition, molecular simulations of the movement of the ring structures around the dione dihedral indicated that the ability of the compounds to inhibit CEs was due, in part, to rotational constraints enforced by the dione moiety. Overall, these studies identify subdomains within the aromatic ethane-1,2-diones, that are responsible for CE inhibition.
引用
收藏
页码:5543 / 5550
页数:8
相关论文
共 41 条
[1]   Chemoproteomics as a basis for post-genomic drug discovery [J].
Beroza, P ;
Villar, HO ;
Wick, MM ;
Martin, GR .
DRUG DISCOVERY TODAY, 2002, 7 (15) :807-814
[2]   Characterisation and clinical management of CPT-11 (irinotecan)-induced adverse events: The European perspective [J].
Bleiberg, H ;
Cvitkovic, E .
EUROPEAN JOURNAL OF CANCER, 1996, 32A :S18-S23
[3]   PURIFICATION AND CHARACTERIZATION OF A HUMAN LIVER COCAINE CARBOXYLESTERASE THAT CATALYZES THE PRODUCTION OF BENZOYLECGONINE AND THE FORMATION OF COCAETHYLENE FROM ALCOHOL AND COCAINE [J].
BRZEZINSKI, MR ;
ABRAHAM, TL ;
STONE, CL ;
DEAN, RA ;
BOSRON, WF .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (09) :1747-1755
[4]   Pharmacokinetics and molecular detoxication [J].
Cashman, JR ;
Perotti, BYT ;
Berkman, CE ;
Lin, J .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1996, 104 :23-40
[5]  
Danks Mary K, 2004, Methods Mol Med, V90, P247
[6]  
Danks MK, 1999, CLIN CANCER RES, V5, P917
[7]  
DEWAR MJS, 1989, HETEROCYCLES, V28, P1135
[8]   GROUND STATES OF CONJUGATED MOLECULES .11. IMPROVED TREATMENT OF HYDROCARBONS [J].
DEWAR, MJS ;
DELLANO, C .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1969, 91 (04) :789-&
[9]   Investigation of classification methods for the prediction of activity in diverse chemical libraries [J].
Dixon, SL ;
Villar, HO .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1999, 13 (05) :533-545
[10]   Bioactive diversity and screening library selection via affinity fingerprinting [J].
Dixon, SL ;
Villar, HO .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1998, 38 (06) :1192-1203